James Crowe
Faculty Member
Last active: 3/31/2019

  1. Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans. Grifoni A, Pham J, Sidney J, O'Rourke PH, Paul S, Peters B, Martini SR, de Silva AD, Ricciardi MJ, Magnani DM, Silveira CGT, Maestri A, Costa PR, de-Oliveira-Pinto LM, de Azeredo EL, Damasco PV, Phillips E, Mallal S, de Silva AM, Collins M, Durbin A, Diehl SA, Cerpas C, Balmaseda A, Kuan G, Coloma J, Harris E, Crowe JE, Stone M, Norris PJ, Busch M, Vivanco-Cid H, Cox J, Graham BS, Ledgerwood JE, Turtle L, Solomon T, Kallas EG, Watkins DI, Weiskopf D, Sette A (2017) J Virol 91(24)
    › Primary publication · 28978707 (PubMed) · PMC5709580 (PubMed Central)
  2. Principles of Broad and Potent Antiviral Human Antibodies: Insights for Vaccine Design. Crowe JE (2017) Cell Host Microbe 22(2): 193-206
    › Primary publication · 28799905 (PubMed) · PMC5700460 (PubMed Central)
  3. Monoclonal Antibodies Against the Staphylococcus aureus Bicomponent Leukotoxin AB Isolated Following Invasive Human Infection Reveal Diverse Binding and Modes of Action. Thomsen IP, Sapparapu G, James DBA, Cassat JE, Nagarsheth M, Kose N, Putnam N, Boguslawski KM, Jones LS, Wood JB, Creech CB, Torres VJ, Crowe JE (2017) J Infect Dis 215(7): 1124-1131
    › Primary publication · 28186295 (PubMed) · PMC5426380 (PubMed Central)
  4. Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination. Nivarthi UK, Kose N, Sapparapu G, Widman D, Gallichotte E, Pfaff JM, Doranz BJ, Weiskopf D, Sette A, Durbin AP, Whitehead SS, Baric R, Crowe JE, de Silva AM (2017) J Virol 91(5)
    › Primary publication · 28031369 (PubMed) · PMC5309932 (PubMed Central)
  5. Epitope and Paratope Mapping Reveals Temperature-Dependent Alterations in the Dengue-Antibody Interface. Lim XX, Chandramohan A, Lim XE, Crowe JE, Lok SM, Anand GS (2017) Structure 25(9): 1391-1402.e3
    › Primary publication · 28823471 (PubMed)
  6. A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein. Mousa JJ, Kose N, Matta P, Gilchuk P, Crowe JE (2017) Nat Microbiol : 16271
    › Primary publication · 28134924 (PubMed) · PMC5463187 (PubMed Central)
  7. A human antibody against Zika virus crosslinks the E protein to prevent infection. Hasan SS, Miller A, Sapparapu G, Fernandez E, Klose T, Long F, Fokine A, Porta JC, Jiang W, Diamond MS, Crowe JE, Kuhn RJ, Rossmann MG (2017) Nat Commun : 14722
    › Primary publication · 28300075 (PubMed) · PMC5356071 (PubMed Central)
  8. Teaching a Clone to Walk, One Step at a Time. Crowe JE (2016) Cell 166(6): 1360-1361
    › Primary publication · 27610559 (PubMed)
  9. Structures of Ebola virus GP and sGP in complex with therapeutic antibodies. Pallesen J, Murin CD, de Val N, Cottrell CA, Hastie KM, Turner HL, Fusco ML, Flyak AI, Zeitlin L, Crowe JE, Andersen KG, Saphire EO, Ward AB (2016) Nat Microbiol 1(9): 16128
    › Primary publication · 27562261 (PubMed) · PMC5003320 (PubMed Central)
  10. Structural basis for norovirus neutralization by an HBGA blocking human IgA antibody. Shanker S, Czakó R, Sapparapu G, Alvarado G, Viskovska M, Sankaran B, Atmar RL, Crowe JE, Estes MK, Prasad BV (2016) Proc Natl Acad Sci U S A 113(40): E5830-E5837
    › Primary publication · 27647885 (PubMed) · PMC5056091 (PubMed Central)